Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
1.
Minim Invasive Neurosurg ; 54(1): 33-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21506066

ABSTRACT

INTRODUCTION: Surgical site infection (SSI) in the setting of lumbar fusion is associated with significant morbidity and medical resource utilization. To date, there have been no studies conducted with sufficient power to directly compare the incidence of SSI following minimally invasive (MIS) vs. open TLIF procedures. Furthermore, studies are lacking that quantify the direct medical cost of SSI following fusion procedures. We set out to determine the incidence of SSI in patients undergoing MIS vs. open TLIF reported in the literature and to determine the direct hospital cost associated with the treatment of SSI following TLIF at our institution. METHODS: A systematic Medline search was performed to identify all published studies assessing SSI after MIS or open TLIF. The cumulative incidence of SSI was calculated from all reported cohorts and compared between MIS vs. open TLIF. In order to determine the direct hospital costs associated with the treatment of SSI following TLIF, we retrospectively reviewed 120 consecutive TLIFs performed at our institution, assessed the incidence of SSI, and calculated the SSI-related hospital costs from accounting and billing records. RESULTS: To date, there have been 10 MIS-TLIF cohorts (362 patients) and 20 open-TLIF cohorts (1 133 patients) reporting incidences of SSI. The cumulative incidence of reported SSI was significantly lower for MIS vs. open-TLIF (0.6% vs. 4.0%, p=0.0005). In our experience with 120 open TLIF procedures, SSI occurred in 6 (5.0%) patients. The mean hospital cost associated with the treatment of SSI following TLIF was $ 29,110 in these 6 cases. The 3.4% decrease in reported incidence of SSI for MIS vs. open-TLIF corresponds to a direct cost savings of $ 98,974 per 100 MIS-TLIF procedures performed. CONCLUSIONS: Post-operative wound infections following TLIF are costly complications. MIS vs. open TLIF is associated with a decreased reported incidence of SSI in the literature and may be a valuable tool in reducing hospital costs associated with spine care.


Subject(s)
Hospital Costs , Lumbar Vertebrae/surgery , Minimally Invasive Surgical Procedures/adverse effects , Spinal Fusion/adverse effects , Spinal Fusion/methods , Surgical Wound Infection/economics , Surgical Wound Infection/epidemiology , Cohort Studies , Cost-Benefit Analysis/methods , Cost-Benefit Analysis/trends , Hospital Costs/trends , Humans , Incidence , Surgical Wound Infection/prevention & control
2.
Peptides ; 32(2): 258-65, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21126552

ABSTRACT

Non-specific binding of Y receptor agonists to intact CHO cells, and to CHO cell or rat brain particulates, is much greater for human neuropeptide Y (hNPY) compared to porcine peptide Y (pPYY), and especially relative to human pancreatic polypeptide (hPP). This binding of hNPY is reduced by alkali cations in preference to non-ionic chaotrope urea, while the much lower non-specific binding of pPYY is more sensitive to urea. The difference could mainly be due to the 10-16 stretch in 36-residue Y agonists (residues 8-14 in N-terminally clipped 34-peptides), located in the sector that contains all acidic residues of physiological Y agonists. Anionic pairs containing aspartate in the 10-16 zone could be principally responsible for non-specific attachments, but may also aid the receptor site binding. Two such pairs are found in hNPY, one in pPYY, and none in hPP. The hydroxyl amino acid residue at position 13 in mammalian PYY and PP molecules could lower conformational plasticity and the non-selective binding via intrachain hydrogen bonding. The acidity of this tract could also be important in agonist selectivity of the Y receptor subtypes. The differences point to an evolutionary reduction of promiscuous protein binding from NPY to PP, and should also be important for Y agonist selectivity within NPY receptor group, and correlate with partial agonism and out-of group cross-reactivity with other receptors.


Subject(s)
Neuropeptides/metabolism , Peptide Hormones/metabolism , Receptors, Neuropeptide Y/agonists , Receptors, Neuropeptide Y/metabolism , Amino Acid Motifs/physiology , Amino Acid Sequence , Animals , Binding Sites/physiology , CHO Cells , Cell Membrane/drug effects , Cell Membrane/metabolism , Cerebral Cortex/metabolism , Cricetinae , Cricetulus , Detergents/pharmacology , Gastrointestinal Hormones/metabolism , HEK293 Cells , Humans , Mice , Molecular Sequence Data , Neuropeptide Y/chemistry , Neuropeptide Y/metabolism , Neuropeptides/chemistry , Pancreatic Polypeptide/chemistry , Pancreatic Polypeptide/metabolism , Peptide Fragments , Peptide Hormones/chemistry , Peptide YY/chemistry , Peptide YY/metabolism , Perchlorates/pharmacology , Protein Binding/drug effects , Protein Binding/physiology , Protein Structure, Secondary/physiology , Rats , Sodium Compounds/pharmacology , Sus scrofa , Transfection , Ultracentrifugation , Urea/pharmacology
3.
Mini Rev Med Chem ; 9(3): 329-39, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19275726

ABSTRACT

The heptahelical G protein coupling receptors oligomerize extensively via transmembrane domains, in association with heterotrimeric G proteins. This provides higher affinity for agonists, conformational stability necessary for signal transduction, and protection from intracellular proteinases. The oligomerization is relevant to organismic pathophysiology and could be targeted by natural or modified agonists.


Subject(s)
Protein Multimerization , Protein Structure, Quaternary , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/metabolism , Animals , Humans , Protein Interaction Domains and Motifs/physiology , Protein Subunits/chemistry , Protein Subunits/physiology , Signal Transduction/physiology
4.
J Recept Signal Transduct Res ; 28(5): 437-51, 2008.
Article in English | MEDLINE | ID: mdl-18946765

ABSTRACT

In conditions precluding activation of G proteins, the binding of agonists to dimers of the neuropeptide Y (NPY) Y2 receptor shows two components of similar size, but differing in affinity. The dimers of all NPY receptors are solubilized as approximately 180-kDa complexes containing one G protein alpha beta gamma trimer. These heteropentamers are stable to excess agonists, chelators, and alkylators. However, dispersion in the weak surfactant cholate releases approximately 300-kDa complexes. These findings indicate that both protomers in the Y2 dimer are associated with G protein heterotrimers, but the extent of interaction depends on affinity for the agonist peptide. The G protein in contact with the first-liganded, higher-affinity protomer should have a stronger interaction with the receptor and a larger probability of activation.


Subject(s)
GTP-Binding Proteins/agonists , GTP-Binding Proteins/metabolism , Receptors, Neuropeptide Y/metabolism , Animals , CHO Cells , Cricetinae , Cricetulus , Estrenes/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Humans , Mice , Phosphodiesterase Inhibitors/pharmacology , Protein Multimerization , Pyrrolidinones/pharmacology , Rabbits , Receptors, Neuropeptide Y/chemistry
5.
Regul Pept ; 150(1-3): 88-94, 2008 Oct 09.
Article in English | MEDLINE | ID: mdl-18585408

ABSTRACT

The neuropeptide Y (NPY) Y2 receptors and the pancreatic polypeptide Y4 receptors from rabbit kidney cortex are isolated largely as approximately 180 kDa complexes constituted of one receptor dimer and one G-protein heterotrimer, similar to NPY receptors expressed in the Chinese hamster ovary (CHO) cells. As expected, kidney and CHO cell Y2 dimers are converted into monomers by increasing concentrations of a selective agonist. Prevalence of dimeric Y2 receptors in the kidney could be related to low plasma levels of Y2 agonists, and possibly also to a relatively low concentration of Gi alpha subunits.


Subject(s)
GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , GTP-Binding Proteins/metabolism , Kidney Cortex/metabolism , Receptors, Neuropeptide Y/metabolism , Animals , CHO Cells , Cricetinae , Cricetulus , Dimerization , GTP-Binding Protein alpha Subunits, Gi-Go/genetics , GTP-Binding Proteins/genetics , Male , Protein Binding , Rabbits , Receptors, Neuropeptide Y/agonists , Solubility
6.
J Recept Signal Transduct Res ; 28(3): 245-63, 2008.
Article in English | MEDLINE | ID: mdl-18569526

ABSTRACT

The neuropeptide Y(NPY) Y2 receptors are detected largely as dimers in the clonal expressions in CHO cells and in particulates from rabbit kidney cortex. However, in two areas of the forebrain (rat or rabbit piriform cortex and hypothalamus), these receptors are found mainly as monomers. Evidence is presented that this difference relates to large levels of G proteins containing the Gi alpha -subunit in the forebrain areas. The predominant monomeric status of these Y2 receptors should also be physiologically linked to large synaptic inputs of the agonist NPY. The rabbit kidney and the human CHO cell-expressed Y2 dimers are converted by agonists to monomers in vitro at a similar rate in the presence of divalent cations.


Subject(s)
Kidney/metabolism , Prosencephalon/metabolism , Receptors, Neuropeptide Y/metabolism , Animals , CHO Cells , Cations, Divalent/pharmacology , Cricetinae , Cricetulus , Dimerization , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Humans , Male , Protein Binding/drug effects , Rabbits , Rats , Receptors, Neuropeptide Y/agonists , Signal Transduction/drug effects , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism
7.
Amino Acids ; 35(1): 1-15, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18266053

ABSTRACT

A L(M)xxxD(N, E) motif (x=a non-ionic amino acid residue, most frequently A, S, L or F; small capitals indicating a minor representation) is found in the second transmembrane (tm2) segment of most G-protein coupling metazoan receptors of the rhodopsin family (Rh-GPCRs). Changes in signal transduction, agonist binding and receptor cycling are known for numerous receptors bearing evolved or experimentally introduced mutations in this tm2 motif, especially of its aspartate residue. The [Na(+)] sensitivity of the receptor-agonist interaction relates to this aspartate in a number of Rh-GPCRs. Native non-conservative mutations in the tm2 motif only rarely coincide with significant changes in two other ubiquitous features of the rhodopsin family, the seventh transmembrane N(D)PxxY(F) motif and the D(E)RY(W,F) or analogous sequence at the border of the third transmembrane helix and the second intracellular loop. Native tm2 mutations with Rh-GPCRs frequently result in constitutive signaling, and with visual opsins also in shifts to short-wavelength sensitivity. Substitution of a strongly basic residue for the tm2 aspartate in Taste-2 receptors could be connected to a lack of sodium sensing by these receptors. These properties could be consistent with ionic interactions, and even of ion transfer, that involve the tm2 motif. A decrease in cation sensing by this motif is usually connected to an enhanced constitutive interaction of the mutated receptors with cognate G- proteins, and also relates to both the constitutive and the overall activity of the short-wavelength opsins.


Subject(s)
Amino Acid Motifs/physiology , Evolution, Molecular , Receptors, Cell Surface/metabolism , Rhodopsin/metabolism , Signal Transduction/physiology , Sodium/metabolism , Amino Acid Substitution , Animals , Cations, Monovalent/metabolism , Humans , Protein Structure, Tertiary/physiology , Receptors, Cell Surface/genetics , Rhodopsin/genetics
8.
Br J Pharmacol ; 153(3): 420-31, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17828288

ABSTRACT

We briefly survey the current knowledge and concepts regarding structure and function of the neuropeptide Y Y2 receptor and its agonists, especially as related to pharmacology of the receptor and its roles in pathological processes. Specific structural features are considered that could be responsible for the known compartmentalization and participation of the receptor in cell and tissue organization. This is further discussed in relation to changes of levels of the Y2 receptor in pathological conditions (especially in epilepsy and drug abuse), to endocytosis and recycling, and to participation in wound healing, retinopathy and angiogenesis. Properties of the receptor and of Y2 agonists are considered and reviewed in connection to the negative regulation of transmitter release, feeding, mood and social behavior. The possible involvement of the Y2 receptor in diabetes, carcinogenesis and bone formation is also reviewed.


Subject(s)
Receptors, Neuropeptide Y/agonists , Receptors, Neuropeptide Y/metabolism , Animals , Endocytosis/physiology , Epilepsy/drug therapy , Epilepsy/physiopathology , Feeding Behavior/physiology , Humans , Neovascularization, Physiologic/physiology , Substance-Related Disorders/physiopathology , Wound Healing/physiology
9.
Regul Pept ; 144(1-3): 72-81, 2007 Dec 04.
Article in English | MEDLINE | ID: mdl-17651824

ABSTRACT

Human neuropeptide Y Y2 receptors expressed in CHO cells are largely oligomeric, and upon solubilization are recovered by density gradient centrifugation as approximately 180 kDa complexes of receptor dimers and G-protein heterotrimers. A large fraction of the receptors is inactivated in the presence of pertussis toxin, in parallel with inactivation of Gi alpha subunits (with half-periods of about 4 h for both). This is accompanied by a very long-lasting loss of receptor dimers and of masked surface Y2 sites (an apparent receptor reserve pre-coupled mainly to Gi alpha subunit-containing G-proteins). However, surface Y2 receptors accessible to large peptide agonists are much less sensitive to the toxin. All surface Y2 receptors are rapidly blocked by Y2 antagonist BIIE0246, with a significant loss of the dimers, but with little change of basal Gi activity. However, both dimers and Y2 receptor compartmentalization are restored within 24 h after removal of the antagonist. In CHO cells, the maintenance and organization of Y2 receptors appear to critically depend on functional pertussis toxin-sensitive G-proteins.


Subject(s)
GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Pertussis Toxin/pharmacology , Receptors, Neuropeptide Y/metabolism , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Benzazepines/pharmacology , CHO Cells , Cricetinae , Cricetulus , Dimerization , Humans , Protein Subunits , Receptors, Neuropeptide Y/antagonists & inhibitors , Solubility
10.
Peptides ; 28(2): 203-13, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17194507

ABSTRACT

Neuropeptide Y (NPY) is one of the most abundant neuropeptides, and is likely to be present at nanomolar levels over extended periods in the synaptic space of many forebrain areas. This might be linked to an evolved generalized toning activity through a number of other peptide receptors that use C-terminally amidated agonists (with LHRH and orexin receptors and GIR as examples). However, the Y1 and Y2 receptors (which constitute the bulk of Y receptors active in the neural matrix) possess subnanomolar affinities that, at saturating NPY levels, could produce excessive signaling, as well as receptor losses via repeated endocytosis. The related Y4 receptor shows an even higher agonist affinity, and faces the same problem in visceral and neural locations accessible to pancreatic polypeptide (PP). An examination of agonist peptide interaction with Y receptors shows that Y1 and Y4 receptors in particular (as located on either the intact cells, or on particulates derived from various cell types) develop a blockade dependent on ligand concentration, with the blocking ranks of [NPY]>>[peptide YY] (PYY) for the Y1, and [human PP]>>>[PYY-related Y4 agonist] for the Y4 receptor. This blockade is also echoed in a concentration-related reduction in biological activity of primary agonists (NPY and PP), resembling a partial agonism, and is influenced especially by the allosteric interactivity of agonists. With the Y2 receptor, the blocking by agonists is less pronounced, but the signaling by NPY-related peptides is apparently less than with PYY-related agonists. The extended occupancy and self-attenuation of primary agonist activity at Y receptors could represent an evolutionary solution contributing to a balancing of metabolic signaling, agonist clearance and receptor conservation.


Subject(s)
Endocytosis , Receptors, Neuropeptide Y/agonists , Adenylyl Cyclases/metabolism , Animals , CHO Cells , Cricetinae , Cricetulus , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Humans , Rats , Receptors, Neuropeptide Y/metabolism
11.
Regul Pept ; 139(1-3): 128-35, 2007 Mar 01.
Article in English | MEDLINE | ID: mdl-17175038

ABSTRACT

The Y(2) receptor for neuropeptide Y (NPY) interacts with pertussis toxin (PTX)-sensitive G-proteins, but little is known about interdependence of their levels and functions. We found that PTX reduces Y(2) receptors expressed in CHO cells in parallel to inactivation of Gi G-proteins, to loss of inhibition by Y(2) agonists of forskolin-stimulated adenylyl cyclase, and to decrease in the binding of GTP-gamma-S. These losses were attenuated by the endosome alkalinizer ammonium chloride. Affinity of the Y(2) receptor was not changed by PTX treatment. Prolonged treatment induced a large decrease of Y(2) receptor immunoreactivity (more than 70% in 48 h). The Gi(3) alpha-subunit immunoreactivity decreased slowly (about 46% in 48 h). There was a significant increase in Gq alpha immunoreactivity and in fraction of Y(2) binding sensitive to a Gq-selective antagonist. Possibly linked to that, the surface Y(2) sites and the internalization of the Y(2) receptor were less than 40% reduced. However, the abundant masked Y(2) sites were eliminated by the toxin, and could be mainly coupled to PTX-sensitive G-proteins.


Subject(s)
GTP-Binding Proteins/metabolism , Pertussis Toxin/pharmacology , Receptors, Neuropeptide Y/metabolism , Adenylyl Cyclases/metabolism , Ammonium Chloride/pharmacology , Animals , Blotting, Western , CHO Cells , Cricetinae , Cricetulus , Gene Expression , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Humans , Protein Binding/drug effects , Receptors, Neuropeptide Y/genetics
12.
Regul Pept ; 132(1-3): 91-101, 2005 Dec 15.
Article in English | MEDLINE | ID: mdl-16213038

ABSTRACT

Internalization of cloned rat or human Y4 receptors expressed in Chinese hamster ovary (CHO) cells increased with concentration of all types of Y4 agonists, including human and rat pancreatic polypeptides, the Y1 receptor group co-agonists possessing C-terminal TRPRY.NH2 pentapeptide, and a C-terminally amidated dimeric nonapeptide related to neuropeptide Y, GR231118. These peptides also inhibited forskolin-stimulated adenylyl cyclase activity in Y4 receptor-expressing cells, and stimulated the binding of 35S-labeled GTP-gamma-S to pertussis toxin-sensitive G-proteins in particulates from these cells. Peptide VD-11 (differing from GR231118 only by C-terminal oxymethylation) acted as a competitive antagonist in all of the above processes. Agonist-induced stimulation of the Y4 receptor internalization persisted in the presence of allosteric inhibitors of hPP binding, N5-substituted amilorides, which also were relatively little active in G-protein stimulation and cyclase inhibition by Y4 agonists. Acceleration of Y4 receptor internalization by agonists apparently is related to relaxation of allosteric constraints to ligand attachment and sequestration of the receptor-ligand complex.


Subject(s)
Peptides/pharmacology , Receptors, Neuropeptide Y/agonists , Receptors, Neuropeptide Y/metabolism , Adenylyl Cyclases/metabolism , Animals , Arsenicals/pharmacology , CHO Cells , Cloning, Molecular , Cricetinae , Cricetulus , Female , Humans , Peptides, Cyclic/pharmacology , Rats , Receptors, Neuropeptide Y/antagonists & inhibitors
13.
Regul Pept ; 107(1-3): 49-62, 2002 Jul 15.
Article in English | MEDLINE | ID: mdl-12137966

ABSTRACT

In Chinese hamster ovary (CHO) cells expressing the cloned guinea-pig Y1 receptor, the saturable, receptor-linked internalization of NPY (NPY)-related peptides showed the rank order of human/rat neuropeptide Y (hNPY)>pig/rat peptide YY (pPYY)>=(Pro(34))human PYY>(Leu(31),Pro(34))hNPY>(Leu(31),Pro(34))hPYY>>BVD-11 (a selective Y1 antagonist). All agonists accessed similar numbers of Y1 sites in particulates from disrupted cells, with relatively small affinity variation. The rate of internalization could significantly depend on the overall interactivity of the agonist peptide (reflected in sensitivity to chaotropic agents, as well as in the level of non-saturable binding and internalization). Concentration-dependent inhibition of the agonist-driven CHO-Y1 internalization was found with filipin III (a cholesterol-complexing macrolide), and confirmed with inhibitors of clathrin lattice formation, phenylarsine oxide (PAO) and sucrose. In the concentration range affecting Y1 internalization, none of the above treatments or agents significantly alter agonist affinity for Y1 cell surface or particulate receptors. Largely similar responses to the above inhibitors were observed in CHO-Y1 cells for internalization of human transferrin. Internalization of CHO-Y1 receptor apparently is driven by NPY in strong preference to other naturally encountered agonists. At 37 degrees C, most of the internalized receptor is rapidly recycled through endosome-like membrane elements, detectable in Percoll gradients.


Subject(s)
Endosomes/drug effects , Receptors, Neuropeptide Y/agonists , Animals , Arsenicals/pharmacology , Binding Sites , Binding, Competitive , CHO Cells , Cloning, Molecular , Cricetinae , Cricetulus , Filipin/pharmacology , Guinea Pigs , Iodine Radioisotopes , Kinetics , Neuropeptide Y/metabolism , Receptors, Neuropeptide Y/genetics , Receptors, Neuropeptide Y/metabolism , Sucrose/pharmacology , Temperature
14.
Peptides ; 22(6): 887-98, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11390018

ABSTRACT

Ligand binding to rodent pancreatic polypeptide-responding neuropeptide Y (NPY) receptors (here termed PP/NPY receptors), or to cloned Y4 or Y5 receptors, is selectively inhibited by amiloride, peptide or alkylating modulators of sodium transport. The PP/NPY and Y4 receptors are also selectively blocked by human or rat pancreatic polypeptide (PP) and the blocking peptides are not dissociated by high concentrations of alkali chlorides (which restore most of the binding of subtype-selective agonists to Y1 and Y2 sites). The PP/NPY receptors could also be blocked by NPY and related full-length peptides, including Y1-selective agonists (IC50 300-400 pM). The cloned Y(4) receptors from three species are much less sensitive to NPY or PYY. The sensitivity of both the PP/NPY sites and the Y(4) sites to Y2-selective peptides is quite low. The ligand attachment to PP/NPY sites is also very sensitive to peptidic Y1 antagonist ((Cys31,NVal34NPY27-36))2, which however blocks these sites at much higher molarities. Blockade of PP/NPY and Y4 sites by agonist peptides can be largely prevented by N5-substituted amiloride modulators of Na+ transport, and by RFamide NRNFLRF.NH2, but not by Ca2+ channel blockers, or by inhibitors of K+ transport. Protection of both PP/NPY and Y4 sites against blockade by human or rat pancreatic polypeptide is also afforded by short N-terminally truncated NPY-related peptides. The above results are consistent with a stringent and selective activity regulation for rabbit PP/NPY receptor(s) that may serve to differentiate agonists and constrain signaling, and could involve transporter-like interactants.


Subject(s)
Pancreas/metabolism , Receptors, Neuropeptide Y/antagonists & inhibitors , Signal Transduction , Sodium/metabolism , Animals , Binding Sites , Binding, Competitive , Biological Transport , Brain/metabolism , CHO Cells , Calcium Channels/metabolism , Cloning, Molecular , Cricetinae , Dose-Response Relationship, Drug , Humans , Inhibitory Concentration 50 , Kidney/metabolism , Kidney Cortex/metabolism , Kinetics , Ligands , Male , Protein Binding , Rabbits , Rats
15.
Eur J Biochem ; 268(4): 877-86, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11179953

ABSTRACT

Guinea-pig neuropeptide Y1 and rat pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells were internalized rapidly upon attachment of selective peptide agonists. The Y1 and Y2, but not the Y4, receptor also internalized the nonselective neuropeptide Y receptor agonist, human/rat neuropeptide Y. The internalization of guinea-pig neuropeptide Y2 receptor expressed in Chinese hamster ovary cells was small at 37 degrees C, and essentially absent at or below 15 degrees C, possibly in connection to the large molecular size of the receptor-ligand complexes (up to 400 kDa for the internalized fraction). The rate of intake was strongly temperature dependent, with essentially no internalization at 6 degrees C for any receptor. Internalized receptors were largely associated with light, endosome-like particulates. Sucrose dose-dependently decreased the internalization rate for all receptors, while affecting ligand attachment to cell membrane sites much less. Internalization of the Y1 and the Y4 receptors could be blocked, and that of the Y2 receptor significantly inhibited, by phenylarsine oxide, which also unmasked spare cell-surface receptors especially abundant for the Y2 subtype. The restoration of Y1 and Y4 receptors after agonist peptide pretreatment was decreased significantly by cycloheximide and monensin. Thus, in Chinese hamster ovary cells the Y1 and Y4 receptors have much larger subcellular dynamics than the Y2 receptor. This differential could also hold in organismic systems, and is comparable with the known differences in internalization of angiotensin, bradykinin, somatostatin and opioid receptor subtypes.


Subject(s)
Down-Regulation , Receptors, Neuropeptide Y/genetics , Alkylating Agents/pharmacology , Animals , Arsenicals/pharmacology , CHO Cells , Cloning, Molecular , Cricetinae , Down-Regulation/drug effects , Endocytosis/drug effects , Guinea Pigs , Kinetics , Neuropeptide Y/metabolism , Pancrelipase/metabolism , Rats , Receptors, Neuropeptide Y/agonists , Receptors, Neuropeptide Y/metabolism , Subcellular Fractions/metabolism , Sucrose/pharmacology , Temperature , Transfection
16.
Neurosci Lett ; 298(1): 1-4, 2001 Jan 26.
Article in English | MEDLINE | ID: mdl-11154821

ABSTRACT

Chronic nicotine treatment (4 mg/kg per day; 14 days) significantly reduced the affinity and density of orexin-A binding sites in the anterior hypothalamus of rat brain. There was a significantly lower sensitivity of orexin-A binding to orexin peptides, to the related secretin and pituitary adenylate cyclase activating peptide, and to unrelated neuropeptide Y (NPY). This change correlated with selective downregulation of a fraction of hypothalamic NPY Y(1) receptors. In previous studies, we have demonstrated an increase in the levels of orexin-A peptide and NPY in discrete hypothalamic areas upon nicotine treatment. This finding contradicts an expected increase in the production of these orexigenic peptides in a model where an inverse relationship is observed between food consumption and nicotine treatment. This study provides a possible explanation to this inconsistency in that a decrease in affinity of orexin-A binding could reduce neural orexin signaling, which may contribute to decreased food intake observed in smokers and animals chronically treated with nicotine.


Subject(s)
Carrier Proteins/metabolism , Hypothalamus/metabolism , Intracellular Signaling Peptides and Proteins , Neuropeptides/metabolism , Nicotine/pharmacology , Animals , Binding Sites , Binding, Competitive , Down-Regulation , Nicotine/administration & dosage , Orexins , Rats , Rats, Sprague-Dawley
17.
Mol Cell Endocrinol ; 164(1-2): 239-49, 2000 Jun.
Article in English | MEDLINE | ID: mdl-11026575

ABSTRACT

Implants of diethylstilbestrol inducing anterior pituitary prolactinomas in female Fischer-344 rats produced a considerable elevation of high-affinity binding of either rat or human pancreatic polypeptide (hPP). No comparable upregulation of high-affinity binding sites was noted for the ligand [125I](Leu31,Pro34)hPYY (LP-PYY) (masked by 2 nM hPP to force selectivity for the Y1 sites), or of the Y2-selective ligand [125I]hPYY(3-36). The Y5-like sites displayed the rank order of potency of hPP = rPP, hNPY, LP-PYY > pPYY(1-36) > hNPY(2-36) > hPYY(3-36) >> aPP, similar to the previously described rabbit kidney or hypothalamic Y5-like receptors. The PP binding in the anterior pituitary was not sensitive to the Y1-selective non-peptidic antagonist BIBP-3226. The PP binding was highly sensitive to alkali metal cations, and to a N5-substituted amiloride antagonist of sodium transport, but not to a C2-guanido substituted amiloride antagonist of sodium channels. The binding was also sensitive to phospholipase C antagonist U-73122, and to alkylating alpha-adrenergic agonist chloroethylclonidine. Lactotrophs isolated in Percoll gradients after enzymic dispersion of the anterior pituitary gland retained the high-affinity PP binding. Following removal of estrogen implants, the hPP binding sites decreased to very low levels within 3 days, in parallel to the decrease of plasma prolactin.


Subject(s)
Pancreas/physiology , Pituitary Gland, Anterior/physiology , Receptors, Neuropeptide Y/physiology , Animals , Estrogens/pharmacology , Female , Humans , Hypertrophy , Pituitary Gland, Anterior/pathology , Rabbits , Rats , Rats, Inbred F344 , Up-Regulation
18.
Endocrinology ; 141(10): 3623-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11014216

ABSTRACT

Orexins are two recently discovered neuropeptides that can stimulate food intake. As the chronic use of tobacco typically leads to a reduction in body weight, it is of interest to determine whether nicotine, the major biologically active tobacco ingredient, has an effect on orexin metabolism in the brain. Using a semiquantitative RT-PCR technique, the levels of messenger RNA (mRNA) for prepro-orexin, orexin A (OX1-R) and orexin B (OX2-R) receptors were 20-50% higher in rats receiving nicotine for 14 days at the level of 2-4 mg/kg day compared with rats receiving saline solvent alone. In animals treated with nicotine at 4 mg/kg x day, the expression levels of mRNA for prepro-orexin, OX1-R, and OX2-R were significantly higher compared with those in either the free-feeding control or pair-fed saline control rats. RIA data indicated that both orexin A and orexin B peptide levels were significantly elevated (45-54%; P < 0.01) in the dorsomedial nucleus (DMH) of the nicotine-treated rats compared with either solvent-only or pair-fed controls. Additionally, orexin B was significantly elevated (83%; P < 0.01), over levels in both types of the control animals, in the paraventricular nucleus (PVN) region. In summary, we demonstrated that an inverse association between nicotine and food intake as well as body weight held with doses comparable to those consumed by average human smokers. Moreover, our data indicated that chronic exposure to nicotine can induce a long-term increase in the expression levels of prepro-orexin and their receptor mRNA in the rat hypothalamus and in the levels of orexin A in the DMH and orexin B in the DMH and PVN among the six hypothalamic regions that we examined.


Subject(s)
Brain/metabolism , Carrier Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Neuropeptides/metabolism , Nicotine/pharmacology , Receptors, Neuropeptide/metabolism , Animals , Body Weight/drug effects , Carrier Proteins/genetics , Dose-Response Relationship, Drug , Eating/drug effects , Hypothalamus/metabolism , Male , Neuropeptides/genetics , Orexin Receptors , Orexins , Protein Precursors/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred Strains , Rats, Sprague-Dawley , Receptors, G-Protein-Coupled , Receptors, Neuropeptide/genetics , Tissue Distribution , Up-Regulation
19.
Brain Res ; 867(1-2): 157-64, 2000 Jun 09.
Article in English | MEDLINE | ID: mdl-10837809

ABSTRACT

Epidemiological studies have shown an inverse relationship between cigarette smoking and body weight. In rodents, a negative correlation between nicotine and body weight has been reported, but this observation was largely derived from studies where relatively high doses of nicotine ( approximately 12 mg/kg/day) were used. In the current study, we showed that a negative relationship also holds for low doses of nicotine that are comparable to that consumed by average human smokers (<6 mg/kg/day). We also demonstrated that 14 days of nicotine administration (4 mg/kg/day) reduced average daily food intake by 19.5% (P<0.01) in the free-feeding nicotine-treated group compared to saline controls. No significant differences in body weight were detected between the nicotine-treated and pair-fed groups. To determine whether the effects of nicotine on food intake and body weight were related to neuropeptide Y (NPY) expression, semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) and radioimmunoassay were utilized to measure NPY mRNA and peptide levels in various regions of the hypothalamus. Significantly higher levels of NPY mRNA (ca. 20-50%) and peptide (ca. 24-69%) were only detected in the nicotine-treated groups. In addition, significantly higher NPY contents were also obtained in two hypothalamic areas of pair-fed control animals. In summary, our data suggest that the pharmacological effects of nicotine on food intake and body weight may be mediated by changes in hypothalamic NPY levels, a neuropeptide that is pivotal to the hypothalamic regulation of food intake.


Subject(s)
Hypothalamus/physiology , Neuropeptide Y/genetics , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Eating/drug effects , Gene Expression/drug effects , Hypothalamus/chemistry , Male , Neuropeptide Y/analysis , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley
20.
Chem Biol ; 7(6): 385-93, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10873835

ABSTRACT

BACKGROUND: The brevetoxins are marine neurotoxins that interfere with the normal functions of the voltage-gated Na(+) channel. We have identified two brevetoxin derivatives that do not exhibit pharmacological properties typical of the brevetoxins and that function as brevetoxin antagonists. RESULTS: PbTx-3 and benzoyl-PbTx-3 elicited Na(+) channel openings during steady-state depolarizations; however, two PbTx-3 derivatives retained their ability to bind to the receptor, but did not elicit Na(+) channel openings. alpha-Naphthoyl-PbTx-3 acted as a PbTx-3 antagonist but did not affect Na(+) channels that were not exposed to PbTx-3. beta-Naphthoyl-PbTx-3 reduced openings of Na(+) channels that were not exposed to PbTx-3. CONCLUSIONS: Some modifications to the brevetoxin molecule do not alter either the binding properties or the activity of these toxins. Larger modifications to the K-ring sidechain do not interfere with binding but have profound effects on their pharmacological properties. This implies a critical function for the K-ring sidechain of the native toxin.


Subject(s)
Marine Toxins/pharmacology , Oxocins , Sodium Channel Blockers , Animals , Cell Line , Male , Marine Toxins/antagonists & inhibitors , Marine Toxins/chemistry , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...